CareDx, Inc.
69.21USD
+0.0500 (+0.07%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on CDNA.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.26▲ | $0.19 | 5 | 0 |
| Next quarter | $0.23▲ | $0.17 | 5 | 0 |
| Current year | $1.2▲ | $0.93 | 5 | 0 |
| Next year | $1.29▲ | $1.13 | 4 | 1 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.23 | $0.37 | +0.14 (+59.5%) |
| 2026-03-31 | $0.13 | $0.34 | +0.21 (+161.5%) |
| 2025-12-31 | $0.23 | $0.12 | -0.11 (-47.1%) |
| 2025-09-30 | $0.14 | $0.28 | +0.14 (+97.6%) |
95 ratings from 13 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Canaccord Genuity | Maintained | Buy | $65 $80 | Oct 19, 2026 |
| BTIG | Maintained | Buy | $60 $74 | Sep 24, 2026 |
| Canaccord Genuity | Initiated | Buy | $65 | Sep 2, 2026 |
| BTIG | Maintained | Buy | $45 $60 | Aug 6, 2026 |
| HC Wainwright & Co. | Reiterated | Neutral | $46 | Jul 31, 2026 |
| BTIG | Maintained | Buy | $28 $45 | Jul 16, 2026 |
| BTIG | Maintained | Buy | $26 $28 | Apr 29, 2026 |
| BTIG | Maintained | Buy | $25 $26 | Feb 26, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $18 $21 | Feb 25, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $14 $18 | Dec 15, 2025 |
| BTIG | Maintained | Buy | $22 $25 | Nov 6, 2025 |
| BTIG | Reiterated | Buy | $22 | Sep 23, 2025 |
| BTIG | Reiterated | Buy | $22 | Sep 12, 2025 |
| William Blair | Initiated | Market Perform | — | Aug 26, 2025 |
| Wells Fargo | Maintained | Equal-Weight | $19 $14 | Aug 8, 2025 |
| Craig-Hallum | Maintained | Buy | $40 $26 | Jul 18, 2025 |
| Stephens & Co. | Reiterated | Overweight | $40 | May 5, 2025 |
| HC Wainwright & Co. | Reiterated | Neutral | $25 | May 5, 2025 |
| Goldman Sachs | Maintained | Buy | $34 $26 | Apr 17, 2025 |
| HC Wainwright & Co. | Maintained | Neutral | $26 $25 | Mar 3, 2025 |
| Stephens & Co. | Reiterated | Overweight | $40 | Feb 27, 2025 |
| Wells Fargo | Upgraded from Underweight | Equal-Weight | $28 $24 | Jan 15, 2025 |
| HC Wainwright & Co. | Reiterated | Neutral | $26 | Jan 14, 2025 |
| BTIG | Maintained | Buy | $40 $35 | Nov 5, 2024 |
| HC Wainwright & Co. | Reiterated | Neutral | — | Oct 22, 2024 |
92 filings from 21 insiders · 12 buy / 13 sell over 6m
Officers and directors of CDNA, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Goldberg MichaelDirector | Grant | 588 | — | — | Oct 2, 2026 |
| Meng JessicaOfficer, Chief Commercial Officer | Tax | 2.6k | $66.23 | $173k | Oct 1, 2026 |
| Novack Jeffrey AdamOfficer, Secretary and General Counsel | Tax | 997 | $66.23 | $66k | Oct 1, 2026 |
| Hanna John Walter JRDirector; Officer, President and CEO | Tax | 8.5k | $66.23 | $564k | Oct 1, 2026 |
| Kennedy KeithOfficer, CFO & COO | Tax | 3.0k | $66.23 | $200k | Oct 1, 2026 |
| Meng JessicaOfficer, Chief Commercial Officer | Tax | 6.7k | $52.37 | $350k | Sep 12, 2026 |
| Kennedy KeithOfficer, CFO & COO | Tax | 8.2k | $52.37 | $430k | Sep 12, 2026 |
| NOVACK JEFFREY ADAMGeneral Counsel | Sell | 2.7k | $46.15 | $124k | Aug 5, 2026 |
| BICKERSTAFF GEORGE W IIIDirector | Sell | 20.0k | $46.28 | $926k | Aug 5, 2026 |
| GOLDBERG MICHAEL DDirector | Sell | 44.7k | $47.06 | $2.10M | Aug 4, 2026 |
| COURNOYER CHRISTINE MDirector | Sell | 16.0k | $46.94 | $751k | Aug 4, 2026 |
| HANNA JOHN WALTER JRChief Executive Officer | Sell | 118.0k | $36.11 | $4.46M | Jul 16, 2026 |
| VALANTINE HANNAH A.Director | Sell | 28.8k | $36.14 | $1.04M | Jul 16, 2026 |
| HANNA JOHN WALTER JRChief Executive Officer | Exercise | 118.0k | $8.20 | $968k | Jul 16, 2026 |
| VALANTINE HANNAH A.Director | Exercise | 28.8k | $7.96 | $425k | Jul 16, 2026 |
| GOLDBERG MICHAEL DDirector | Grant | 1.7k | — | — | Jul 2, 2026 |
| HANNA JOHN WALTER JRChief Executive Officer | Sell | 40.0k | $29.00 | $1.17M | Jun 29, 2026 |
| HANNA JOHN WALTER JRChief Executive Officer | Exercise | 70.0k | $8.20 | $574k | Jun 29, 2026 |
| VALANTINE HANNAH A.Director | Sell | 12.1k | $23.11 | $280k | Jun 15, 2026 |
| HANNA JOHN WALTER JRChief Executive Officer | Sell | 17.7k | $24.03 | $425k | Jun 15, 2026 |
No analyst notes on CDNA yet.
Analyst Ratings
6 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 0 | 5 | 2 | 0 | 0 | Buy2.29 |
| 1 mo ago | 0 | 5 | 2 | 0 | 0 | Buy2.29 |
| 2 mo ago | 0 | 4 | 3 | 0 | 0 | Buy2.43 |
| 3 mo ago | 0 | 3 | 4 | 0 | 0 | Hold2.57 |
Members whose judged calls on CDNA have played out most reliably.
No settled calls on CDNA yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice